CD19 and psoriasis vulgaris: Finally, the proportion of CD19+HLA-DR+B cells in PBMCs from patients with psoriasis vulgaris at the active stage wassignificantly upregulated compared with patients with erythrodermic psoriasis and HCs(P<0.001; Figure 3).